Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2012 Oct 12;12:139. doi: 10.1186/1471-230X-12-139

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright ©2012 Yamasaki et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Cumulative survival rates between corresponding groups. (A) There was no significant difference between the IFN-treated hepatitis C group (Group A) and the general resident group (Group A^′). (B) There was a significant difference between the hepatitis C group not receiving IFN treatment (Group B) and the general resident group (Group B^′) (p < 0.0001). (C) There was no significant difference between the hepatitis C group that achieved SVR by IFN treatment (Group A1) and the general resident group (Group A1^′). (D) There was no significant difference between the IFN treatment group with non-SVR in the hepatitis C group (Group A2) and the general resident group (Group A2^′) (p = 0.153). All survival rates were calculated using the Kaplan–Meier method. Solid and dotted lines represent the hepatitis C and general resident groups, respectively.